Last update 23 Jan 2025

APE1 x Hydroxylase

Basic Info

Related Targets
APE1Hydroxylase

Related

2
Drugs associated with APE1 x Hydroxylase
CB-7645
Target
APE1 x Hydroxylase
Mechanism
APE1 inhibitors [+1]
Active Org.-
Originator Org.
The Institute of Cancer Research: Royal Cancer HospitalThe Institute of Cancer Research: Royal Cancer Hospital
Active Indication-
Inactive Indication
Prostatic Cancer
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
MDL-105831
Target
5α-reductase x APE1 x Hydroxylase
Mechanism
5α-reductase inhibitors [+2]
Active Org.-
Originator Org.
Hoechst Marion Roussel, Inc.Hoechst Marion Roussel, Inc.
Active Indication-
Inactive Indication
Breast Cancer [+1]
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with APE1 x Hydroxylase
Login to view more data
100 Translational Medicine associated with APE1 x Hydroxylase
Login to view more data
0 Patents (Medical) associated with APE1 x Hydroxylase
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free